U.S. Office REITs Stock News

IATA lowers its global airline profit outlook, citing pressure on sector-wide earnings. American Airlines Group (NasdaqGS:AAL) cuts its own profit expectations in response to higher fuel costs. Geopolitical conflicts in the Middle East add operational disruptions and further cost uncertainty for the carrier. American Airlines Group, one of the largest U.S. carriers, is adjusting to a tougher industry backdrop as IATA revises profit expectations for airlines globally. For investors, the...

VinFast Auto (NasdaqGS:VFS) opened 2026 with Q1 revenue of about ₫23.1 trillion (₫23,111,052 million) and a net loss of roughly ₫28.1 trillion (₫28,059,960 million), translating to a basic EPS loss of ₫11,993.81. The trailing 12 months show revenue of around ₫96.98 trillion and a net loss of about ₫109.77 trillion, or EPS of ₫46,924.97. Over recent quarters the company has seen revenue range from approximately ₫16.3 trillion in Q1 2025 to ₫39.16 trillion in Q4 2025, with basic EPS losses...

International Paper is partnering with Canadian Pacific Kansas City on a new 468,000-square-foot packaging facility in Mississippi. The site is planned with direct rail access to support inbound materials and outbound shipments across North America. The facility is expected to be operational in Q4 2027 as part of International Paper's broader transformation in packaging and logistics. For investors watching NYSE:IP, this project comes amid a mixed share performance backdrop. The stock...

In the past, several law firms, including Levi & Korsinsky, Rosen Law Firm and Holzer & Holzer, announced securities class action lawsuits against Regencell Bioscience Holdings after the company disclosed a Department of Justice subpoena into trading of its ordinary shares. The cases focus on allegations that Regencell issued materially false or misleading statements and failed to disclose its vulnerability to market manipulation during the October 28, 2024 to October 31, 2025 period...

Investors may be wondering whether Rexford Industrial Realty is starting to look attractively priced, or if the current share price still leaves little room for upside. The stock closed at US$33.96 and has been under pressure recently, with the share price down 2.1% over the past week, 6.4% over the past month, 13.0% year to date and 2.8% over the last year. This extends a 25.2% decline over three years and 33.0% over five years. Recent coverage has focused on how industrial real estate...

Grand Canyon Education recently disclosed that it is in discussions with Grand Canyon University to amend their Master Services Agreement, potentially extending the partnership by eight years and revising how service fees are calculated. This contract review matters because it could reshape Grand Canyon Education’s revenue mix, concentration risk, and long-term reliance on its largest university partner. We’ll now examine how the potential eight-year extension of the Grand Canyon University...

MongoDB (MDB) recently reported first quarter results and raised its full year 2027 revenue and earnings guidance, even as higher for longer interest rate expectations pressured growth stocks in broader trading. See our latest analysis for MongoDB. MongoDB's share price has been volatile recently, with a 7 day share price return down 12.71%, yet a 30 day share price return of 17.73% and a 90 day share price return of 30.31% hinting at rebuilding momentum despite a year to date share price...

Recent share performance and business scale Loma Negra Compañía Industrial Argentina Sociedad Anónima (LOMA) has seen its stock decline 14.7% year to date, while the past 3 months show a gain of 4.4% and the month is broadly flat. For context on the underlying business, the company reports revenue of roughly $850,476.19 and net income of about $36,113.48. Its operations span cement, concrete, aggregates, railway services and other related activities in Argentina. See our latest analysis for...

Why Hotel101 Global Holdings Stock Is Drawing Attention Now Hotel101 Global Holdings (NasdaqCM:HBNB) has been drawing attention after a period of weak share performance, with the stock down 8% over the past month and 33% over the past 3 months. For investors, the recent slide sits alongside a market value of about US$1.32b, revenue of US$75.87 million from property development, and a net loss of US$26.71 million. This combination is prompting a closer look at the business model. See our...

Yesway (YSWY) is drawing attention after its recent share performance, with the stock down about 15% over the past month following a modest single-day and past-week decline. See our latest analysis for Yesway. That 14.6% decline in the 30 day share price return, alongside a small year to date share price gain of 3.7% with the stock now at US$22.01, suggests recent momentum has cooled after a firmer start to the year. If you are looking beyond Yesway and want ideas with a similar risk on...

Celcuity (CELC) has moved into focus after reporting Phase 3 VIKTORIA-1 data for gedatolisib and securing FDA Priority Review, alongside a newly priced US$500 million convertible senior notes offering due 2032. See our latest analysis for Celcuity. Despite the positive Phase 3 VIKTORIA-1 data and FDA Priority Review, Celcuity’s share price has pulled back sharply in recent weeks, with a 30 day share price return of down 33.3%, even as the 1 year total shareholder return is very large and...

Encompass Health recently completed a US$500,000,000 private offering of 5.875% senior notes due 2034, primarily to refinance existing 4.500% 2028 notes, repay revolving credit facility borrowings, and cover related fees, while also opening plans for a new 36-bed inpatient rehabilitation hospital in Bridgeport, West Virginia to replace a closed 19-bed unit. This combination of balance sheet reshaping through longer-dated, higher-coupon unsecured debt and continued investment in specialized...

In its latest quarterly update, Fidelity National Financial reported US$3.23 billion in revenue, an 18.2% year-on-year increase that nonetheless fell short of analyst expectations for both sales and earnings per share. This combination of growth and an earnings miss highlighted a gap between the company’s recent operating performance and the projections embedded in prior analyst models. Now we will consider how this revenue and EPS shortfall against expectations affects Fidelity National...

Warby Parker (NYSE:WRBY) has been added to the S&P SmallCap 600 index, a move that can influence its visibility with index funds and institutional investors. The company also announced a partnership with Google to develop AI-powered intelligent eyewear, bringing smart functionality to its consumer eyewear offering. Warby Parker operates across omnichannel retail and e-commerce, selling prescription glasses, sunglasses, contacts and related eye care services. The S&P SmallCap 600 addition...

Over the last 7 days, the United States market has experienced a 2.7% drop, though it has risen by 23% over the past year, with earnings forecasted to grow by 17% annually. In this fluctuating environment, identifying undervalued stocks can present opportunities for investors seeking to capitalize on potential growth and favorable market estimates.

Over the last 7 days, the United States market has dropped 2.7%, yet it has shown resilience with a 23% rise over the past year and expectations for earnings to grow by 17% annually in the coming years. In this context, growth companies with high insider ownership, such as ATRenew and two others we'll explore, can be particularly appealing as they often indicate strong internal confidence in their long-term potential.

Over the last 7 days, the United States market has dropped 2.7%, but it has risen by 23% in the past year, with earnings forecasted to grow by 17% annually. For investors willing to explore beyond well-known stocks, penny stocks—though a somewhat outdated term—still represent an intriguing investment area due to their affordability and potential for growth. This article highlights three penny stocks that stand out for their financial strength and resilience, offering compelling opportunities...

Over the last 7 days, the United States market has experienced a 2.7% drop, yet it remains up by 23% over the past year with earnings forecasted to grow by 17% annually. In such dynamic conditions, dividend stocks that offer consistent payouts and potential for capital appreciation can be an attractive option for investors seeking stability and income.

Apogee Therapeutics (APGE) stock is in focus after positive 16-week Phase 2 APEX data for zumilokibart in atopic dermatitis, followed by a milestone-based, non-dilutive financing package of up to US$1.3b from Blackstone Life Sciences. See our latest analysis for Apogee Therapeutics. After a sharp rally tied to the Phase 2 APEX data and US$1.3b Blackstone financing, Apogee’s share price has eased 4.5% over the last day, although the 1-year total shareholder return of 106.85% points to strong...

CPS Technologies (CPSH) has filed a follow-on equity offering to raise US$9.6 million by issuing 1,200,000 common shares at US$8 each in a registered direct deal, introducing fresh capital and potential dilution. See our latest analysis for CPS Technologies. The follow on offering comes after a sharp run, with a 30 day share price return of 95.21% and year to date share price return of 142.19%. The 1 year total shareholder return of 181.82% points to strong longer term momentum despite...

Tarsus Pharmaceuticals (TARS) has been drawing attention after recent trading swings, with the stock closing at US$59.64 while showing mixed returns over the past month and past 3 months, alongside a positive one year track record. See our latest analysis for Tarsus Pharmaceuticals. The share price has been under pressure in recent months, with a 90 day share price return down 18.32% and year to date share price return down 26.16%. At the same time, the 1 year total shareholder return sits at...

Event context and recent stock performance Palvella Therapeutics (PVLA) has drawn fresh attention after recent trading saw the stock close at US$105.25. This move comes alongside a year-to-date gain of 5% and a 1-year total return near 3x. See our latest analysis for Palvella Therapeutics. Recent trading has been choppy, with the share price down 3.15% on the day, 6.52% over the past week and 25.94% over the past quarter. At the same time, the 1 year total shareholder return sits near 3x,...

Why Azenta (AZTA) is on investors’ radar today Azenta (AZTA) continues to draw attention after a mixed stretch of performance that includes a gain over the past month but weaker returns year to date and over the past year. With a market value of about US$1.0b and reported revenue of US$596.5m, the company sits in an interesting spot for investors comparing growth potential, profitability and valuation against other life sciences service providers. See our latest analysis for Azenta. At the...

Some Natera, Inc. ( NASDAQ:NTRA ) shareholders may be a little concerned to see that the Lead Independent Director...